We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Lab-in-a-Backpack Offers Fast, Affordable, Reliable COVID-19 Testing

By LabMedica International staff writers
Posted on 28 Jan 2022
Print article
Image: Lab-in-a-Backpack (Photo courtesy of Queen Mary University of London)
Image: Lab-in-a-Backpack (Photo courtesy of Queen Mary University of London)

Researchers have created a simple COVID-19 testing lab that fits into a backpack providing a cheap and effective solution for low income or remote areas.

In a new study, scientists from Queen Mary University of London (London, UK) have shown that their lab-in-a-backpack approach is as effective as commercially available COVID-19 tests at detecting SARS-CoV-2. The compact kit is relatively inexpensive to make, costing USD 51 in total. It could offer an alternative testing solution for resource-poor countries or remote areas with little access to well-equipped testing labs or trained personnel to process samples. The testing kit is based on a simple, non-invasive COVID-19 LAMP test and uses low-cost hardware, including a centrifuge made from recycled computer hard drives, called a CentriDrive, to process samples.

The LAMP test is a widely accepted alternative to the commonly used PCR test, has a similar sensitivity but unlike the PCR test does not require temperature cycling, only a single high temperature to amplify any potential virus RNA. This allows the test to be performed with only minimal equipment and reagents. Because the LAMP test uses saliva samples, it also avoids the need for invasive, uncomfortable nasal swabs. However, the high costs of commercially available LAMP tests, as well as the expensive lab equipment required to run them, means that current commercial approaches aren’t suitable for remote locations, or in-home testing.

According to the researchers, the next steps will include making the kit instructions even more understandable so that people can use them regardless of their experience or language, as well as validating the kit with real patient samples. So, whilst this approach holds promise, further work is needed before the system can be implemented in real-world environments.

“In this study, using the LAMP test method in combination with a low-cost centrifuge, we provided an inexpensive, rapid and accurate method for the detection of COVID-19,” said Emily Lin, lead author of the study. “It will not only provide a viable and inexpensive test kit for regions such as Africa, where innovative solutions are particularly important during the Covid-19 pandemic. It can also be used in resource-rich areas, for example, in high school classrooms to demonstrate how to test for COVID-19.”

“We are excited for the potential of this mobile lab to do COVID-19 tests and the possibility to democratize access to inexpensive testing technology,” said Professor Stoyan Smoukov, Professor of Chemical Engineering at Queen Mary University of London. “It is made possible by our philosophy of creating low-cost instruments whenever possible from advances in electronics, or existing instruments.”

“Reuse is a high-value option for energy and materials sustainability, and we are glad that rather than exporting electronics waste to developing countries, we can export ways to empower people and turn waste computer hard drives into a centrifuge. The COVID-19 test is a timely application, but we also believe with this CentriDrive kit people could perform a large array of routine blood and urine tests, providing a centrifuge away from central hospital facilities,” added Professor Smoukov.

Related Links:
Queen Mary University of London 

Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
New
Chagas Disease Test
LIAISON Chagas

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.